- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 3 - The Provider's Role and Costs Associated With Genetic Testing
It is up to physicians to seek education and training on genetics. Panelists agree that it is important for patients to speak with a genetic counselor even if it is over the phone.
It is up to physicians to seek education and training on genetics. Panelists agree that it is important for patients to speak with a genetic counselor even if it is over the phone. “It may be the physicians responsibility to collect the family history in that office appointment and then know when it would be appropriate to refer to a genetic counselor or a geneticist,” said Ms Nagy.
Dr Berger asks the panelists to address the trends associated with costs in genetic testing. “It’s not only the genetic tests, but it’s the downstream costs,” said Ms Matloff referring to unnecessary surgeries, the wrong surveillance, etc. “Cost has 2 elements, unit price and utilization, and I think that with the Supreme Court decision the unit price is going to go down,” said Dr Finley. “Certainly for BRCA, but probably for other genetic tests as well.” Dr Finely said that it is important to address the cost, underutilization of people that should be tested, and the overutilization of the people that should not be tested.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More
